Antigua and Barbuda vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received 3 doses of
Antigua and Barbuda
99.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
94.0%
in 2024
Antigua and Barbuda rank
1st
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
2nd
Proportion of the target population who received 3 doses of over time
- Antigua and Barbuda
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
How they compare
Antigua and Barbuda currently reports 99.0% against 94.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 5.0%.
That makes Antigua and Barbuda's figure about 1.1 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 1st and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd of 209 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.1% | 95.3% | 2.8% | Antigua and Barbuda |
| 2010s | 97.3% | 93.7% | 3.6% | Antigua and Barbuda |
| 2020s | 96.6% | 94.0% | 2.6% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Antigua and Barbuda or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Antigua and Barbuda, at 99.0% against 94.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Antigua and Barbuda and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 5.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 25 years are reported by both, from 2000 to 2024.
- How do Antigua and Barbuda and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received 3 doses of?
- Antigua and Barbuda ranks 1st and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.